Cargando…

Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA(2) in Macrophages

Lysophosphatidic acid (LPA), one of the simplest phospholipid signaling molecules, participates in formation and disruption of atherosclerotic plaque. Matrix metalloproteinases (MMPs) contribute to atherosclerotic plaque rupture by involving in extracellular matrix (ECM) degradation and then thinnin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Chun, Wang, Fang, Zhao, Zhenwen, Wang, Hongyue, Cong, Xiangfeng, Chen, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406459/ https://www.ncbi.nlm.nih.gov/pubmed/28496416 http://dx.doi.org/10.3389/fphys.2017.00266

Ejemplares similares

Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability
por: Olejarz, Wioletta, et al.
Publicado: (2020)

The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability
por: Li, Tiewei, et al.
Publicado: (2020)

GPR92/LPA(5) lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques
por: Khandoga, Anna L., et al.
Publicado: (2011)

Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway
por: Yang, Jinjing, et al.
Publicado: (2018)

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015)

LPA(3)-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice
por: Wang, Fang, et al.
Publicado: (2020)

Protective Role for LPA(3) in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol
por: Cai, Lin, et al.
Publicado: (2017)

Lysophosphatidic Acid Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury in the Immature Hearts of Rats
por: Chen, Haibo, et al.
Publicado: (2017)

The NF-κB pathway: regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs
por: Cao, Yongjun, et al.
Publicado: (2013)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Lysophosphatidic acid, LPA: a bad boy becomes good
por: Budnik, Lygia T
Publicado: (2003)

Lysophosphatidic Acid (LPA) Signaling in Human and Ruminant Reproductive Tract
por: Wocławek-Potocka, Izabela, et al.
Publicado: (2014)

Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-κB pathway
por: Sigala, Fragiska, et al.
Publicado: (2010)

Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
por: Uchida, Hitoshi, et al.
Publicado: (2014)

Expression of Chitotriosidase in Macrophages Modulates Atherosclerotic Plaque Formation in Hyperlipidemic Mice
por: Yap, Jonathan, et al.
Publicado: (2020)

MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia
por: Plastira, Ioanna, et al.
Publicado: (2020)

Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway
por: Zhang, Jie, et al.
Publicado: (2020)

Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage Subsets
por: Jager, Nynke A., et al.
Publicado: (2015)

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels
por: Ezhov, Marat, et al.
Publicado: (2019)

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
por: Su, Pan, et al.
Publicado: (2022)

Specific Matrix Metalloproteinases Play Different Roles in Intraplaque Angiogenesis and Plaque Instability in Rabbits
por: Liu, Xiao Qiong, et al.
Publicado: (2014)

Modulation of lysophosphatidic acid (LPA) receptor activity: the key to successful neural regeneration?
por: Gross, Isabel, et al.
Publicado: (2019)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
por: Balijepalli, Pravita, et al.
Publicado: (2021)

Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability
por: Ruddy, Jean Marie, et al.
Publicado: (2016)

Carotid Atherosclerotic Plaque Matrix Metalloproteinase-12–Positive Macrophage Subpopulation Predicts Adverse Outcome After Endarterectomy
por: Scholtes, Vincent P. W., et al.
Publicado: (2012)

Matrix Metalloproteinases-7 and Kidney Fibrosis
por: Ke, Ben, et al.
Publicado: (2017)

Lysophosphatidic acid receptors LPA(4) and LPA(6) differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes
por: Hata, Erina, et al.
Publicado: (2016)

Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors
por: Yang, Yifan, et al.
Publicado: (2022)

Relation between TLR4/NF-κB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability
por: Gargiulo, Simona, et al.
Publicado: (2015)

Consistency in Geometry Among Coronary Atherosclerotic Plaques Extracted From Computed Tomography Angiography
por: Liu, Haipeng, et al.
Publicado: (2021)

Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA)
por: Park, Eun Young, et al.
Publicado: (2012)

Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2
por: YANG, DEZHI, et al.
Publicado: (2013)

Lysophosphatidic acid (LPA) 18:1 transcriptional regulation of primary human gingival fibroblasts
por: Cerutis, D. Roselyn, et al.
Publicado: (2014)

Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway
por: Won, Kyung-Jong, et al.
Publicado: (2020)

Dual Role of Lysophosphatidic Acid Receptor 2 (LPA(2)) in Amyotrophic Lateral Sclerosis
por: Puigdomenech-Poch, Maria, et al.
Publicado: (2021)

Increased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability
por: Zhao, Huiying, et al.
Publicado: (2017)

Increased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability
por: Zhao, Huiying, et al.
Publicado: (2018)

Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques
por: Hakimzadeh, Nazanin, et al.
Publicado: (2017)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j2v2ilf8j46dlurr5j41pg1044